Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis
Author(s) -
Jonny Stephens,
Joyce Wong,
R. Broomhead,
Richard Stümpfle,
U. Waheed,
P. Patel,
Stephen J. Brett,
Sanooj Soni
Publication year - 2021
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1093/bjs/znaa168
Subject(s) - medicine , pancreatitis , covid-19 , acute pancreatitis , incidence (geometry) , gastroenterology , amylase , intensive care medicine , pathology , enzyme , disease , biochemistry , chemistry , physics , outbreak , infectious disease (medical specialty) , optics
A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom